Xu Lulu, Xiong Junwei, Li Xinxin, Wang Jiajia, Wang Pengyu, Wu Xiaobin, Wang Jiaxi, Liu Yong, Guo Ran, Fan Xiaohe, Zhu Xiaofeng, Guan Yanzhong
Department of Physiology & Neurobiology, Mudanjiang Medical University, Mudanjiang, 157011, China.
Heilongjiang Province Key Laboratory of Mechanism and Prevention of Substance Dependence Disease, Mudanjiang, 157011, China.
Mol Neurobiol. 2025 Mar;62(3):2889-2902. doi: 10.1007/s12035-024-04447-3. Epub 2024 Aug 24.
Alcohol Use Disorder (AUD), characterized by repeated alcohol consumption and withdrawal symptoms, poses a significant public health issue. Alcohol-induced impairment of the intestinal barrier results in alterations in intestinal permeability and the composition of the intestinal microbiota. Such alterations lead to a reduced relative abundance of intestinal lactic acid bacteria. However, the role of gut microbiota in alcohol consumption is not yet fully understood. In this study, we explore the mechanism by which gut microbiota regulates alcohol consumption, specifically using extracellular vesicles derived from Lactobacillus plantarum (L-EVs). L-EVs were administered to Sprague-Dawley rats either through intraperitoneal injection or microinjection into the ventral tegmental area (VTA), resulting in a significant reduction in alcohol consumption 72 hours after withdrawal. The observed reduction was akin to the effect of an intra-VTA microinjection of Brain-Derived Neurotrophic Factor (BDNF). Intriguingly, the microinjection of K252a (a Trk B antagonist) into the VTA blocked the reducing effect of L-EVs on alcohol consumption. The intraperitoneal injection of L-EVs restored the diminished BDNF expression in the VTA of alcohol-dependent rats. Furthermore, L-EVs rescued the low BDNF expression in alcohol-incubated PC12 cells. In conclusion, our study demonstrates that L-EVs attenuated alcohol consumption by enhancing BDNF expression in alcohol-dependent rats, thus suggesting the significant therapeutic potential of L-EVs in preventing excessive alcohol consumption.
酒精使用障碍(AUD),其特征为反复饮酒及戒断症状,是一个重大的公共卫生问题。酒精引起的肠屏障损伤导致肠道通透性及肠道微生物群组成发生改变。此类改变致使肠道乳酸菌的相对丰度降低。然而,肠道微生物群在饮酒行为中的作用尚未完全明确。在本研究中,我们探究肠道微生物群调节饮酒行为的机制,具体使用植物乳杆菌来源的细胞外囊泡(L-EVs)。通过腹腔注射或向腹侧被盖区(VTA)微量注射的方式将L-EVs给予Sprague-Dawley大鼠,在撤药72小时后酒精摄入量显著减少。观察到的减少类似于向VTA微量注射脑源性神经营养因子(BDNF)的效果。有趣的是,向VTA微量注射K252a(一种Trk B拮抗剂)可阻断L-EVs对酒精摄入量的减少作用。腹腔注射L-EVs可恢复酒精依赖大鼠VTA中降低的BDNF表达。此外,L-EVs可挽救酒精孵育的PC12细胞中低水平的BDNF表达。总之,我们的研究表明,L-EVs通过增强酒精依赖大鼠的BDNF表达来减少酒精摄入量,从而提示L-EVs在预防过度饮酒方面具有显著的治疗潜力。